CN104082739B - A kind of full nutrition half digestion special medicine purposes formula food and preparation method thereof - Google Patents
A kind of full nutrition half digestion special medicine purposes formula food and preparation method thereof Download PDFInfo
- Publication number
- CN104082739B CN104082739B CN201410287197.1A CN201410287197A CN104082739B CN 104082739 B CN104082739 B CN 104082739B CN 201410287197 A CN201410287197 A CN 201410287197A CN 104082739 B CN104082739 B CN 104082739B
- Authority
- CN
- China
- Prior art keywords
- formula food
- special medicine
- medicine purposes
- full nutrition
- purposes formula
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 235000013305 food Nutrition 0.000 title claims abstract description 66
- 235000016709 nutrition Nutrition 0.000 title claims abstract description 62
- 230000035764 nutrition Effects 0.000 title claims abstract description 57
- 239000003814 drug Substances 0.000 title claims abstract description 56
- 230000029087 digestion Effects 0.000 title claims abstract description 55
- 238000002360 preparation method Methods 0.000 title abstract description 8
- 239000000126 substance Substances 0.000 claims abstract description 24
- 235000015112 vegetable and seed oil Nutrition 0.000 claims abstract description 24
- 239000008158 vegetable oil Substances 0.000 claims abstract description 24
- 235000019742 Vitamins premix Nutrition 0.000 claims abstract description 23
- 229910052500 inorganic mineral Inorganic materials 0.000 claims abstract description 23
- 239000011707 mineral Substances 0.000 claims abstract description 23
- 125000002057 carboxymethyl group Chemical group [H]OC(=O)C([H])([H])[*] 0.000 claims abstract description 21
- 239000000843 powder Substances 0.000 claims abstract description 20
- 102000011632 Caseins Human genes 0.000 claims abstract description 13
- 108010076119 Caseins Proteins 0.000 claims abstract description 13
- 102000004407 Lactalbumin Human genes 0.000 claims abstract description 13
- 108090000942 Lactalbumin Proteins 0.000 claims abstract description 13
- 108010073771 Soybean Proteins Proteins 0.000 claims abstract description 13
- 239000000413 hydrolysate Substances 0.000 claims abstract description 13
- 235000019710 soybean protein Nutrition 0.000 claims abstract description 13
- 150000004667 medium chain fatty acids Chemical class 0.000 claims abstract description 11
- 229940080237 sodium caseinate Drugs 0.000 claims abstract description 11
- 150000001720 carbohydrates Chemical class 0.000 claims abstract description 10
- 239000000203 mixture Substances 0.000 claims abstract description 9
- 239000005913 Maltodextrin Substances 0.000 claims description 22
- 229920002774 Maltodextrin Polymers 0.000 claims description 22
- 229940035034 maltodextrin Drugs 0.000 claims description 22
- 235000010755 mineral Nutrition 0.000 claims description 22
- PVXPPJIGRGXGCY-TZLCEDOOSA-N 6-O-alpha-D-glucopyranosyl-D-fructofuranose Chemical group O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1OC[C@@H]1[C@@H](O)[C@H](O)C(O)(CO)O1 PVXPPJIGRGXGCY-TZLCEDOOSA-N 0.000 claims description 15
- NLKNQRATVPKPDG-UHFFFAOYSA-M potassium iodide Chemical compound [K+].[I-] NLKNQRATVPKPDG-UHFFFAOYSA-M 0.000 claims description 15
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 claims description 10
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 claims description 10
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 claims description 10
- TWRXJAOTZQYOKJ-UHFFFAOYSA-L Magnesium chloride Chemical compound [Mg+2].[Cl-].[Cl-] TWRXJAOTZQYOKJ-UHFFFAOYSA-L 0.000 claims description 10
- WCUXLLCKKVVCTQ-UHFFFAOYSA-M Potassium chloride Chemical compound [Cl-].[K+] WCUXLLCKKVVCTQ-UHFFFAOYSA-M 0.000 claims description 10
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 claims description 10
- OVBPIULPVIDEAO-LBPRGKRZSA-N folic acid Chemical compound C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-LBPRGKRZSA-N 0.000 claims description 10
- PUZPDOWCWNUUKD-UHFFFAOYSA-M sodium fluoride Chemical compound [F-].[Na+] PUZPDOWCWNUUKD-UHFFFAOYSA-M 0.000 claims description 10
- XOAAWQZATWQOTB-UHFFFAOYSA-N taurine Chemical compound NCCS(O)(=O)=O XOAAWQZATWQOTB-UHFFFAOYSA-N 0.000 claims description 10
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 claims description 5
- 229910021556 Chromium(III) chloride Inorganic materials 0.000 claims description 5
- AUNGANRZJHBGPY-UHFFFAOYSA-N D-Lyxoflavin Natural products OCC(O)C(O)C(O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-UHFFFAOYSA-N 0.000 claims description 5
- ZAKOWWREFLAJOT-CEFNRUSXSA-N D-alpha-tocopherylacetate Chemical compound CC(=O)OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C ZAKOWWREFLAJOT-CEFNRUSXSA-N 0.000 claims description 5
- OVBPIULPVIDEAO-UHFFFAOYSA-N N-Pteroyl-L-glutaminsaeure Natural products C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)NC(CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-UHFFFAOYSA-N 0.000 claims description 5
- 229960005070 ascorbic acid Drugs 0.000 claims description 5
- 235000010323 ascorbic acid Nutrition 0.000 claims description 5
- 239000011668 ascorbic acid Substances 0.000 claims description 5
- 229960002685 biotin Drugs 0.000 claims description 5
- 235000020958 biotin Nutrition 0.000 claims description 5
- 239000011616 biotin Substances 0.000 claims description 5
- 239000011575 calcium Substances 0.000 claims description 5
- 229910052791 calcium Inorganic materials 0.000 claims description 5
- 229910000019 calcium carbonate Inorganic materials 0.000 claims description 5
- 239000001506 calcium phosphate Substances 0.000 claims description 5
- 229960001231 choline Drugs 0.000 claims description 5
- OEYIOHPDSNJKLS-UHFFFAOYSA-N choline Chemical compound C[N+](C)(C)CCO OEYIOHPDSNJKLS-UHFFFAOYSA-N 0.000 claims description 5
- 229960000359 chromic chloride Drugs 0.000 claims description 5
- QSWDMMVNRMROPK-UHFFFAOYSA-K chromium(3+) trichloride Chemical compound [Cl-].[Cl-].[Cl-].[Cr+3] QSWDMMVNRMROPK-UHFFFAOYSA-K 0.000 claims description 5
- ARUVKPQLZAKDPS-UHFFFAOYSA-L copper(II) sulfate Chemical compound [Cu+2].[O-][S+2]([O-])([O-])[O-] ARUVKPQLZAKDPS-UHFFFAOYSA-L 0.000 claims description 5
- 229910000366 copper(II) sulfate Inorganic materials 0.000 claims description 5
- ZAKOWWREFLAJOT-UHFFFAOYSA-N d-alpha-Tocopheryl acetate Natural products CC(=O)OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C ZAKOWWREFLAJOT-UHFFFAOYSA-N 0.000 claims description 5
- ZPWVASYFFYYZEW-UHFFFAOYSA-L dipotassium hydrogen phosphate Chemical compound [K+].[K+].OP([O-])([O-])=O ZPWVASYFFYYZEW-UHFFFAOYSA-L 0.000 claims description 5
- BVTBRVFYZUCAKH-UHFFFAOYSA-L disodium selenite Chemical compound [Na+].[Na+].[O-][Se]([O-])=O BVTBRVFYZUCAKH-UHFFFAOYSA-L 0.000 claims description 5
- 229960000304 folic acid Drugs 0.000 claims description 5
- 235000019152 folic acid Nutrition 0.000 claims description 5
- 239000011724 folic acid Substances 0.000 claims description 5
- XBDUTCVQJHJTQZ-UHFFFAOYSA-L iron(2+) sulfate monohydrate Chemical compound O.[Fe+2].[O-]S([O-])(=O)=O XBDUTCVQJHJTQZ-UHFFFAOYSA-L 0.000 claims description 5
- 229910001629 magnesium chloride Inorganic materials 0.000 claims description 5
- 229940099596 manganese sulfate Drugs 0.000 claims description 5
- 239000011702 manganese sulphate Substances 0.000 claims description 5
- 235000007079 manganese sulphate Nutrition 0.000 claims description 5
- SQQMAOCOWKFBNP-UHFFFAOYSA-L manganese(II) sulfate Chemical compound [Mn+2].[O-]S([O-])(=O)=O SQQMAOCOWKFBNP-UHFFFAOYSA-L 0.000 claims description 5
- VLAPMBHFAWRUQP-UHFFFAOYSA-L molybdic acid Chemical compound O[Mo](O)(=O)=O VLAPMBHFAWRUQP-UHFFFAOYSA-L 0.000 claims description 5
- 239000011772 phylloquinone Substances 0.000 claims description 5
- 239000001103 potassium chloride Substances 0.000 claims description 5
- 235000011164 potassium chloride Nutrition 0.000 claims description 5
- ZUFQODAHGAHPFQ-UHFFFAOYSA-N pyridoxine hydrochloride Chemical compound Cl.CC1=NC=C(CO)C(CO)=C1O ZUFQODAHGAHPFQ-UHFFFAOYSA-N 0.000 claims description 5
- 229960004172 pyridoxine hydrochloride Drugs 0.000 claims description 5
- 235000019171 pyridoxine hydrochloride Nutrition 0.000 claims description 5
- 239000011764 pyridoxine hydrochloride Substances 0.000 claims description 5
- 150000004508 retinoic acid derivatives Chemical class 0.000 claims description 5
- 229960002477 riboflavin Drugs 0.000 claims description 5
- 235000019192 riboflavin Nutrition 0.000 claims description 5
- 239000002151 riboflavin Substances 0.000 claims description 5
- 150000003839 salts Chemical class 0.000 claims description 5
- 239000001509 sodium citrate Substances 0.000 claims description 5
- NLJMYIDDQXHKNR-UHFFFAOYSA-K sodium citrate Chemical compound O.O.[Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NLJMYIDDQXHKNR-UHFFFAOYSA-K 0.000 claims description 5
- 239000011775 sodium fluoride Substances 0.000 claims description 5
- 235000013024 sodium fluoride Nutrition 0.000 claims description 5
- 239000011781 sodium selenite Substances 0.000 claims description 5
- 235000015921 sodium selenite Nutrition 0.000 claims description 5
- 229960001471 sodium selenite Drugs 0.000 claims description 5
- NASFKTWZWDYFER-UHFFFAOYSA-N sodium;hydrate Chemical compound O.[Na] NASFKTWZWDYFER-UHFFFAOYSA-N 0.000 claims description 5
- 229960003080 taurine Drugs 0.000 claims description 5
- UIERGBJEBXXIGO-UHFFFAOYSA-N thiamine mononitrate Chemical compound [O-][N+]([O-])=O.CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N UIERGBJEBXXIGO-UHFFFAOYSA-N 0.000 claims description 5
- 229940042585 tocopherol acetate Drugs 0.000 claims description 5
- QORWJWZARLRLPR-UHFFFAOYSA-H tricalcium bis(phosphate) Chemical compound [Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O QORWJWZARLRLPR-UHFFFAOYSA-H 0.000 claims description 5
- 229940078499 tricalcium phosphate Drugs 0.000 claims description 5
- 229910000391 tricalcium phosphate Inorganic materials 0.000 claims description 5
- 235000019731 tricalcium phosphate Nutrition 0.000 claims description 5
- 239000011715 vitamin B12 Substances 0.000 claims description 5
- 239000011647 vitamin D3 Substances 0.000 claims description 5
- 229940118149 zinc sulfate monohydrate Drugs 0.000 claims description 5
- RNZCSKGULNFAMC-UHFFFAOYSA-L zinc;hydrogen sulfate;hydroxide Chemical compound O.[Zn+2].[O-]S([O-])(=O)=O RNZCSKGULNFAMC-UHFFFAOYSA-L 0.000 claims description 5
- 238000001694 spray drying Methods 0.000 claims description 3
- 201000010099 disease Diseases 0.000 abstract description 8
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract description 8
- 230000036737 immune function Effects 0.000 abstract description 8
- 230000002708 enhancing effect Effects 0.000 abstract description 6
- 239000000047 product Substances 0.000 abstract description 2
- 238000011084 recovery Methods 0.000 abstract description 2
- 230000000052 comparative effect Effects 0.000 description 20
- 230000006870 function Effects 0.000 description 17
- 241000699670 Mus sp. Species 0.000 description 13
- 241000699666 Mus <mouse, genus> Species 0.000 description 11
- 230000037396 body weight Effects 0.000 description 8
- 238000000034 method Methods 0.000 description 6
- 239000013642 negative control Substances 0.000 description 6
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 5
- ABSPRNADVQNDOU-UHFFFAOYSA-N Menaquinone 1 Natural products C1=CC=C2C(=O)C(CC=C(C)C)=C(C)C(=O)C2=C1 ABSPRNADVQNDOU-UHFFFAOYSA-N 0.000 description 4
- AFCARXCZXQIEQB-UHFFFAOYSA-N N-[3-oxo-3-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)propyl]-2-[[3-(trifluoromethoxy)phenyl]methylamino]pyrimidine-5-carboxamide Chemical compound O=C(CCNC(=O)C=1C=NC(=NC=1)NCC1=CC(=CC=C1)OC(F)(F)F)N1CC2=C(CC1)NN=N2 AFCARXCZXQIEQB-UHFFFAOYSA-N 0.000 description 4
- 229930003779 Vitamin B12 Natural products 0.000 description 4
- AGVAZMGAQJOSFJ-WZHZPDAFSA-M cobalt(2+);[(2r,3s,4r,5s)-5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl] [(2r)-1-[3-[(1r,2r,3r,4z,7s,9z,12s,13s,14z,17s,18s,19r)-2,13,18-tris(2-amino-2-oxoethyl)-7,12,17-tris(3-amino-3-oxopropyl)-3,5,8,8,13,15,18,19-octamethyl-2 Chemical compound [Co+2].N#[C-].[N-]([C@@H]1[C@H](CC(N)=O)[C@@]2(C)CCC(=O)NC[C@@H](C)OP(O)(=O)O[C@H]3[C@H]([C@H](O[C@@H]3CO)N3C4=CC(C)=C(C)C=C4N=C3)O)\C2=C(C)/C([C@H](C\2(C)C)CCC(N)=O)=N/C/2=C\C([C@H]([C@@]/2(CC(N)=O)C)CCC(N)=O)=N\C\2=C(C)/C2=N[C@]1(C)[C@@](C)(CC(N)=O)[C@@H]2CCC(N)=O AGVAZMGAQJOSFJ-WZHZPDAFSA-M 0.000 description 4
- 210000004698 lymphocyte Anatomy 0.000 description 4
- SHUZOJHMOBOZST-UHFFFAOYSA-N phylloquinone Natural products CC(C)CCCCC(C)CCC(C)CCCC(=CCC1=C(C)C(=O)c2ccccc2C1=O)C SHUZOJHMOBOZST-UHFFFAOYSA-N 0.000 description 4
- MBWXNTAXLNYFJB-NKFFZRIASA-N phylloquinone Chemical compound C1=CC=C2C(=O)C(C/C=C(C)/CCC[C@H](C)CCC[C@H](C)CCCC(C)C)=C(C)C(=O)C2=C1 MBWXNTAXLNYFJB-NKFFZRIASA-N 0.000 description 4
- 235000019175 phylloquinone Nutrition 0.000 description 4
- 229960001898 phytomenadione Drugs 0.000 description 4
- 230000002980 postoperative effect Effects 0.000 description 4
- 210000000582 semen Anatomy 0.000 description 4
- 210000000952 spleen Anatomy 0.000 description 4
- 235000019163 vitamin B12 Nutrition 0.000 description 4
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 3
- 241001465754 Metazoa Species 0.000 description 3
- VCUFZILGIRCDQQ-KRWDZBQOSA-N N-[[(5S)-2-oxo-3-(2-oxo-3H-1,3-benzoxazol-6-yl)-1,3-oxazolidin-5-yl]methyl]-2-[[3-(trifluoromethoxy)phenyl]methylamino]pyrimidine-5-carboxamide Chemical compound O=C1O[C@H](CN1C1=CC2=C(NC(O2)=O)C=C1)CNC(=O)C=1C=NC(=NC=1)NCC1=CC(=CC=C1)OC(F)(F)F VCUFZILGIRCDQQ-KRWDZBQOSA-N 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- 230000003203 everyday effect Effects 0.000 description 3
- 230000007661 gastrointestinal function Effects 0.000 description 3
- 238000003304 gavage Methods 0.000 description 3
- 230000036039 immunity Effects 0.000 description 3
- 210000002540 macrophage Anatomy 0.000 description 3
- 210000001616 monocyte Anatomy 0.000 description 3
- 230000000242 pagocytic effect Effects 0.000 description 3
- 230000035755 proliferation Effects 0.000 description 3
- 238000012360 testing method Methods 0.000 description 3
- ZEMPKEQAKRGZGQ-AAKVHIHISA-N 2,3-bis[[(z)-12-hydroxyoctadec-9-enoyl]oxy]propyl (z)-12-hydroxyoctadec-9-enoate Chemical compound CCCCCCC(O)C\C=C/CCCCCCCC(=O)OCC(OC(=O)CCCCCCC\C=C/CC(O)CCCCCC)COC(=O)CCCCCCC\C=C/CC(O)CCCCCC ZEMPKEQAKRGZGQ-AAKVHIHISA-N 0.000 description 2
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 2
- 101000693916 Gallus gallus Albumin Proteins 0.000 description 2
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 2
- 241001619461 Poria <basidiomycete fungus> Species 0.000 description 2
- 235000019484 Rapeseed oil Nutrition 0.000 description 2
- 239000005018 casein Substances 0.000 description 2
- BECPQYXYKAMYBN-UHFFFAOYSA-N casein, tech. Chemical compound NCCCCC(C(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(CC(C)C)N=C(O)C(CCC(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(C(C)O)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(COP(O)(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(N)CC1=CC=CC=C1 BECPQYXYKAMYBN-UHFFFAOYSA-N 0.000 description 2
- 235000021240 caseins Nutrition 0.000 description 2
- 230000001079 digestive effect Effects 0.000 description 2
- 239000012065 filter cake Substances 0.000 description 2
- 239000008103 glucose Substances 0.000 description 2
- 150000002333 glycines Chemical class 0.000 description 2
- 235000013402 health food Nutrition 0.000 description 2
- 238000007689 inspection Methods 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 238000012423 maintenance Methods 0.000 description 2
- QJGQUHMNIGDVPM-UHFFFAOYSA-N nitrogen group Chemical group [N] QJGQUHMNIGDVPM-UHFFFAOYSA-N 0.000 description 2
- 235000008390 olive oil Nutrition 0.000 description 2
- 239000004006 olive oil Substances 0.000 description 2
- 235000018102 proteins Nutrition 0.000 description 2
- 102000004169 proteins and genes Human genes 0.000 description 2
- 108090000623 proteins and genes Proteins 0.000 description 2
- 230000005180 public health Effects 0.000 description 2
- 210000002966 serum Anatomy 0.000 description 2
- 210000000813 small intestine Anatomy 0.000 description 2
- NHBKXEKEPDILRR-UHFFFAOYSA-N 2,3-bis(butanoylsulfanyl)propyl butanoate Chemical compound CCCC(=O)OCC(SC(=O)CCC)CSC(=O)CCC NHBKXEKEPDILRR-UHFFFAOYSA-N 0.000 description 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
- SRBFZHDQGSBBOR-IOVATXLUSA-N D-xylopyranose Chemical compound O[C@@H]1COC(O)[C@H](O)[C@H]1O SRBFZHDQGSBBOR-IOVATXLUSA-N 0.000 description 1
- 229920001353 Dextrin Polymers 0.000 description 1
- 239000004375 Dextrin Substances 0.000 description 1
- 241000233866 Fungi Species 0.000 description 1
- 206010020751 Hypersensitivity Diseases 0.000 description 1
- 208000002720 Malnutrition Diseases 0.000 description 1
- 240000007930 Oxalis acetosella Species 0.000 description 1
- 235000008098 Oxalis acetosella Nutrition 0.000 description 1
- 235000010240 Paullinia pinnata Nutrition 0.000 description 1
- JPYHHZQJCSQRJY-UHFFFAOYSA-N Phloroglucinol Natural products CCC=CCC=CCC=CCC=CCCCCC(=O)C1=C(O)C=C(O)C=C1O JPYHHZQJCSQRJY-UHFFFAOYSA-N 0.000 description 1
- 244000197580 Poria cocos Species 0.000 description 1
- 235000008599 Poria cocos Nutrition 0.000 description 1
- 241001558929 Sclerotium <basidiomycota> Species 0.000 description 1
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 1
- 230000024932 T cell mediated immunity Effects 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 229960000583 acetic acid Drugs 0.000 description 1
- 208000030961 allergic reaction Diseases 0.000 description 1
- 230000003266 anti-allergic effect Effects 0.000 description 1
- 230000000259 anti-tumor effect Effects 0.000 description 1
- 230000036528 appetite Effects 0.000 description 1
- 235000019789 appetite Nutrition 0.000 description 1
- SRBFZHDQGSBBOR-UHFFFAOYSA-N beta-D-Pyranose-Lyxose Natural products OC1COC(O)C(O)C1O SRBFZHDQGSBBOR-UHFFFAOYSA-N 0.000 description 1
- 235000013361 beverage Nutrition 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 230000002354 daily effect Effects 0.000 description 1
- 235000019425 dextrin Nutrition 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 239000012467 final product Substances 0.000 description 1
- 230000007160 gastrointestinal dysfunction Effects 0.000 description 1
- 230000005176 gastrointestinal motility Effects 0.000 description 1
- 239000012362 glacial acetic acid Substances 0.000 description 1
- 230000002641 glycemic effect Effects 0.000 description 1
- 239000008187 granular material Substances 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 235000008216 herbs Nutrition 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 230000010354 integration Effects 0.000 description 1
- 230000003871 intestinal function Effects 0.000 description 1
- 238000011835 investigation Methods 0.000 description 1
- 230000001071 malnutrition Effects 0.000 description 1
- 235000000824 malnutrition Nutrition 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 238000005399 mechanical ventilation Methods 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 230000000474 nursing effect Effects 0.000 description 1
- 239000002417 nutraceutical Substances 0.000 description 1
- 235000021436 nutraceutical agent Nutrition 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 208000015380 nutritional deficiency disease Diseases 0.000 description 1
- 230000003287 optical effect Effects 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 230000003285 pharmacodynamic effect Effects 0.000 description 1
- QCDYQQDYXPDABM-UHFFFAOYSA-N phloroglucinol Chemical compound OC1=CC(O)=CC(O)=C1 QCDYQQDYXPDABM-UHFFFAOYSA-N 0.000 description 1
- 229960001553 phloroglucinol Drugs 0.000 description 1
- 230000035790 physiological processes and functions Effects 0.000 description 1
- 102000004196 processed proteins & peptides Human genes 0.000 description 1
- 108090000765 processed proteins & peptides Proteins 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 210000002027 skeletal muscle Anatomy 0.000 description 1
- FDRCDNZGSXJAFP-UHFFFAOYSA-M sodium chloroacetate Chemical compound [Na+].[O-]C(=O)CCl FDRCDNZGSXJAFP-UHFFFAOYSA-M 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 239000013589 supplement Substances 0.000 description 1
- 230000009466 transformation Effects 0.000 description 1
- 230000001228 trophic effect Effects 0.000 description 1
- 235000021122 unsaturated fatty acids Nutrition 0.000 description 1
- 150000004670 unsaturated fatty acids Chemical class 0.000 description 1
- 230000010148 water-pollination Effects 0.000 description 1
- 239000012856 weighed raw material Substances 0.000 description 1
- 230000029663 wound healing Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/40—Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pediatric Medicine (AREA)
- Mycology (AREA)
- Nutrition Science (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
Abstract
The invention provides a kind of full nutrition half digestion special medicine purposes formula food and preparation method thereof, full nutrition described in every 100g half digestion special medicine purposes formula food contains: lact albumin hydrolysate 5-15g, albumen 3-8g, soybean protein isolate 1-4g, concentrated lactoalbumin 1-4g, sodium caseinate 0.5-2g, low GI value carbohydrate 37-60g, oligofructose 1-4g, carboxymethyl pachyman 0.005-0.05g, vegetable oil powder 15-22g, medium-chain fatty acid 4-10g, mineral substance premix 3-8g, vitamin premix 0.2-1.4g, each component mix homogeneously is prepared finished product. the present invention synergism by various compositions, it is possible to make full use of the partial digested function after operation in patients, protects, maintains, promotes comprehensive recovery of people digest's function, and adjustment immunologic function, enhancing body resistance against diseases, thus affecting advancing of disease and lapsing to.
Description
Technical field
The present invention relates to a kind of nutritional preparation, particularly relate to a kind of full nutrition half digestion special medicine purposes formula food and preparation method thereof.
Background technology
Investigation shows, nearly 20%-50% inpatient is still had to there is malnutrition in various degree, and the underfed problem of Critical Ill Patient is more prominent, incidence rate, up to 50%, may result in skeletal muscle volume and declines in various degree with strength, gastrointestinal function integrity, immunologic function and anti allergic reaction ability; Acquired Infection increases, poor wound healing, and mechanical ventilation and intensive care unit(ICU) (ICU) extended residence time, complication and case fatality rate increase. Although postoperative 1-2d gastrointestinal motility function starts to recover, but its absorption function is still more weak, and digestive function does not also recover completely; Making full use of the partial digested function after operation in patients, protection, maintenance, the comprehensive of promotion people digest's function recover, and regulate immunologic function, and enhancing body resistance against diseases, thus affecting advancing of disease and lapsing to. There is no recover for postoperative part gastrointestinal function with in bibliographical information in the market, had a degree of digestive function but the trophic function food of whole nutrient protein patient can not be fully relied on again.
Summary of the invention
The present invention provides a kind of full nutrition half digestion special medicine purposes formula food; purpose is in that to make full use of postoperative partial digested function, and protection, maintenance, the comprehensive of promotion people digest's function recover, and regulate immunologic function; enhancing body resistance against diseases, thus affecting advancing of disease and lapsing to.
The first aspect of the invention is to provide a kind of full nutrition half digestion special medicine purposes formula food, contains in full nutrition described in every 100g half digestion special medicine purposes formula food:
Lact albumin hydrolysate 5-15g,
Albumen 3-8g,
Soybean protein isolate 1-4g,
Concentrated lactoalbumin 1-4g,
Sodium caseinate 0.5-2g,
Low GI value carbohydrate 37-60g,
Oligofructose 1-4g,
Carboxymethyl pachyman 0.005-0.05g,
Vegetable oil powder 15-22g,
Medium-chain fatty acid 4-10g,
Mineral substance premix 3-8g,
Vitamin premix 0.2-1.4g.
Wherein, described vegetable oil powder is made up of vegetable oil and edible carrier, and the weight ratio of the two is (40-60): (40-60), vegetable oil and edible carrier is mixed, and spray drying is made powder and namely obtained described vegetable oil powder.
Wherein, described vegetable oil can be one or more in Oleum Arachidis hypogaeae semen, Oleum Glycines, oleum lini, Oleum Gossypii semen, Oleum Ricini, rapeseed oil, Oleum sesami, olive oil, Oleum Camelliae etc.
Preferably, described edible carrier is maltodextrin.
Wherein, described low GI value carbohydrate refers to the carbohydrate of glycemic index≤55.
Wherein
Preferably, described low GI value carbohydrate is isomaltulose and maltodextrin mixture, and the ratio of the two can arbitrarily regulate.
It is further preferred that containing isomaltulose 25-40g, maltodextrin 12-20g in full nutrition half digestion special medicine purposes formula food described in every 100g.
Preferably, in full nutrition described in every 100g half digestion special medicine purposes formula food, the content of described low GI value carbohydrate is 42-56g, more preferably 46-53g, it is most preferred that for 49.76g.
Preferably, full nutrition described in every 100g half digestion special medicine purposes formula food contains:
Lact albumin hydrolysate 7-14g,
Albumen 4-6g,
Soybean protein isolate 0.8-3g,
Concentrated lactoalbumin 0.8-3g,
Sodium caseinate 0.6-1.5g,
Isomaltulose 28-38g,
Maltodextrin 14-18g,
Oligofructose 0.8-3g,
Carboxymethyl pachyman 0.008-0.04g,
Vegetable oil powder 16-20g,
Medium-chain fatty acid 5-8g,
Mineral substance premix 3.5-6g,
Vitamin premix 0.5-1.2g.
It is further preferred that full nutrition half digestion special medicine purposes formula food described in every 100g contains:
Lact albumin hydrolysate 9-10g,
Albumen 4-5g,
Soybean protein isolate 1-2g,
Concentrated lactoalbumin 1.2-2.2g,
Sodium caseinate 0.8-1.2g,
Isomaltulose 30-35g,
Maltodextrin 16-17g,
Oligofructose 1-2g,
Carboxymethyl pachyman 0.01-0.04g,
Vegetable oil powder 17-18g,
Medium-chain fatty acid 6-7g,
Mineral substance premix 4-5g,
Vitamin premix 0.6-1g.
Most preferably, full nutrition described in every 100g half digestion special medicine purposes formula food contains:
Lact albumin hydrolysate 9.54g,
Albumen 4.73g,
Soybean protein isolate 1.66g,
Concentrated lactoalbumin 1.86g,
Sodium caseinate 0.97g,
Isomaltulose 32.86g,
Maltodextrin 16.90g,
Oligofructose 1.70g,
Carboxymethyl pachyman 0.03g,
Vegetable oil powder 17.22g,
Medium-chain fatty acid 6.83g,
Mineral substance premix 4.88g,
Vitamin premix 0.82g.
Preferably, mineral substance premix described in every 1g comprises tricalcium phosphate 18-30mg, calcium carbonate 5-15mg, six hydrated chromium trichloride 0.004-0.01mg, anhydrous cupric sulfate 0.05-0.3mg, Feromax 1-2mg, magnesium chloride 12-25mg, manganese sulfate 0.1-0.5mg, two molybdic acid hydrate sodium 0.005-0.02mg, potassium chloride 18-30mg, dipotassium hydrogen phosphate 70-100mg, sodium selenite 0.001-0.01mg, Zinc sulfate monohydrate 0.8-1.5mg, sodium fluoride 0.05-0.2mg, edible salt 50-70mg, sodium citrate 18-26mg, and surplus is mineral substance premix carrier.
Further preferably, mineral substance premix described in every 1g comprises tricalcium phosphate 22-25mg, calcium carbonate 8-12mg, six hydrated chromium trichloride 0.006-0.008mg, anhydrous cupric sulfate 0.1-0.2mg, Feromax 1.3-1.8mg, magnesium chloride 15-20mg, manganese sulfate 0.2-0.4mg, two molybdic acid hydrate sodium 0.008-0.015mg, potassium chloride 22-25mg, dipotassium hydrogen phosphate 80-90mg, sodium selenite 0.004-0.008mg, Zinc sulfate monohydrate 1-1.2mg, sodium fluoride 0.08-0.12mg, edible salt 55-65mg, sodium citrate 20-24mg, surplus is mineral substance premix carrier.
Most preferably, mineral substance premix described in every 1g comprises tricalcium phosphate 23.368mg, calcium carbonate 10.531mg, six hydrated chromium trichloride 0.007mg, anhydrous cupric sulfate 0.155mg, Feromax 1.505mg, magnesium chloride 18.681mg, manganese sulfate 0.313mg, two molybdic acid hydrate sodium 0.010mg, potassium chloride 23.052mg, dipotassium hydrogen phosphate 87.606mg, sodium selenite 0.006mg, Zinc sulfate monohydrate 1.129mg, sodium fluoride 0.103mg, edible salt 61.122mg, sodium citrate 22.373mg, and surplus is mineral substance premix carrier.
Preferably, described mineral substance premix carrier is maltodextrin.
Preferably, vitamin premix described in every 1g comprises phylloxanthin 0.8-1.5mg, vitamin A acid esters 1500-2500IU, vitamin D3200-300U, Vitamin E acetate 10-18mg, vitamin K1 0.01-0.1mg, thiamine nitrate 1-2mg, riboflavin 0.8-1.5mg, pyridoxine hydrochloride 1-2mg, ascorbic acid 60-100mg, D-VB5 calcium 2-8mg, biotin 28-40mg, folic acid 0.1-0.5mg, nicotiamide 8-15mg, vitamin B12 1-4mg, potassium iodide 0.05-0.1mg, choline 150-300mg, taurine 40-60mg, surplus is vitamin premix carrier.
It is further preferred that vitamin premix described in every 1g comprises phylloxanthin 1-1.2mg, vitamin A acid esters 1800-2200IU, vitamin D3220-250IU, Vitamin E acetate 12-15mg, vitamin K1 0.04-0.06mg, thiamine nitrate 1.2-1.5mg, riboflavin 1-1.2mg, pyridoxine hydrochloride 1.3-1.8mg, ascorbic acid 72-85mg, D-VB5 calcium 4-5mg, biotin 32-35mg, folic acid 0.2-0.3mg, nicotiamide 11-13mg, vitamin B12 1.5-3mg, potassium iodide 0.06-0.09mg, choline 200-250mg, taurine 50-58mg, surplus is vitamin premix carrier.
Most preferably, vitamin premix described in every 1g comprises phylloxanthin 1.195mg, vitamin A acid esters 2043.474IU, vitamin D3240.707IU, Vitamin E acetate 13.869mg, vitamin K1 0.042mg, thiamine nitrate 1.437mg, riboflavin 1.194mg, pyridoxine hydrochloride 1.539mg, ascorbic acid 80.722mg, D-VB5 calcium 4.614mg, biotin 32.501mg, folic acid 0.234mg, nicotiamide 12.471mg, vitamin B12 1.837mg, potassium iodide 0.084mg, choline 210.682mg, taurine 56.942mg, surplus is vitamin premix carrier.
Preferably, described vitamin premix carrier is maltodextrin.
Wherein, in foregoing of the present invention, the preparation method of described carboxymethyl pachyman is known in the art, such as Chen Chun rosy clouds etc. are at " chemical research of carboxymethyl pachyman " (edible fungi of china, 1994,13 (5): 35-36) disclose hydrophily method and two kinds of methods of solvent method prepare carboxymethyl pachyman, and for example Cheng Jin life etc. also discloses that the simple and convenient process for preparing of a kind of carboxymethyl pachyman in " preparation of carboxymethyl pachyman and antitumor pharmacodynamic study " (Youjiang River medical journal, volume 4 phase August 36 in 2008).
Wherein, described full nutrition half digestion special medicine purposes formula food can be granule or electuary. Full nutrition half digestion special medicine purposes formula food can also be made the liquid forms such as beverage.
Full nutrition provided by the invention half digestion special medicine purposes formula food contains the small peptides such as protein and lact albumin hydrolysate such as soybean protein isolate, Chicken Albumin, casein and concentrated lactoalbumin, there is multi-form nitrogenous source, it is prone to digest and assimilate, rich in unsaturated fatty acids such as EPA, DHA, patient's body function and gastrointestinal function are recovered have important function.
Full nutrition provided by the invention half digestion special medicine purposes formula food is especially added with the modified Poria extract carboxymethyl pachyman of integration of edible and medicinal herbs, contributes to improving patient's immunity.
Full nutrition provided by the invention half digestion special medicine purposes formula food adopts the carbohydrate of the low GI such as maltodextrin, isomaltulose, contributes to the control of glucose.
Full nutrition provided by the invention half digestion special medicine purposes formula food is a kind of complex food, it combines soybean protein isolate, Chicken Albumin, casein, concentrated lactoalbumin, the nitrogenous source that lact albumin hydrolysate etc. are multi-form, it is prone to digest and assimilate, patient's immunity is improved in conjunction with carboxymethyl pachyman, in conjunction with maltodextrin, the carbohydrate of the low GI such as isomaltulose, control glucose, synergism by various compositions, postoperative partial digested function can be made full use of, protection, maintain, promote comprehensive recovery of people digest's function, regulate immunologic function, enhancing body resistance against diseases, thus affecting advancing of disease and lapsing to. this full nutrition half digestion special medicine purposes formula food can not only be used for nutraceutical provides nutritional support for gastrointestinal dysfunction patient, also can as the nutritional support food of common patient, being also used as bread and cheese is that normal population or weak crowd eat, and supplements daily required more comprehensive nutrition and functional component.
Detailed description of the invention
Below in conjunction with specific embodiment, the present invention will be further described, to be more fully understood that the present invention.
Embodiment 1
A kind of full nutrition half digestion special medicine purposes formula food, contains in full nutrition described in every 100g half digestion special medicine purposes formula food:
Lact albumin hydrolysate 9.54g,
Albumen 4.73g,
Soybean protein isolate 1.66g,
Concentrated lactoalbumin 1.86g,
Sodium caseinate 0.97g,
Isomaltulose 32.86g,
Maltodextrin 16.90g,
Oligofructose 1.70g,
Carboxymethyl pachyman 0.03g,
Vegetable oil powder 17.22g,
Medium-chain fatty acid 6.83g,
Mineral substance premix 4.88g,
Vitamin premix 0.82g.
Ratio is weighed raw material, raw material is dry mixed to mix homogeneously, namely prepare finished product.
Wherein, described vegetable oil powder is made up of vegetable oil and maltodextrin, and the weight ratio of the two is 1:1, is mixed with maltodextrin by vegetable oil, and spray drying is made powder and get final product. Wherein, described vegetable oil can be one or more in Oleum Arachidis hypogaeae semen, Oleum Glycines, oleum lini, Oleum Gossypii semen, Oleum Ricini, rapeseed oil, Oleum sesami, olive oil, Oleum Camelliae etc.
Wherein, mineral substance premix described in every 1g comprises tricalcium phosphate 23.368mg, calcium carbonate 10.531mg, six hydrated chromium trichloride 0.007mg, anhydrous cupric sulfate 0.155mg, Feromax 1.505mg, magnesium chloride 18.681mg, manganese sulfate 0.313mg, two molybdic acid hydrate sodium 0.010mg, potassium chloride 23.052mg, dipotassium hydrogen phosphate 87.606mg, sodium selenite 0.006mg, Zinc sulfate monohydrate 1.129mg, sodium fluoride 0.103mg, edible salt 61.122mg, sodium citrate 22.373mg, and surplus is maltodextrin.
Wherein, vitamin premix described in every 1g comprises phylloxanthin 1.195mg, vitamin A acid esters 2043.474IU, vitamin D3240.707IU, Vitamin E acetate 13.869mg, vitamin K1 0.042mg, thiamine nitrate 1.437mg, riboflavin 1.194mg, pyridoxine hydrochloride 1.539mg, ascorbic acid 80.722mg, D-VB5 calcium 4.614mg, biotin 32.501mg, folic acid 0.234mg, nicotiamide 12.471mg, vitamin B12 1.837mg, potassium iodide 0.084mg, choline 210.682mg, taurine 56.942mg, surplus is maltodextrin.
Wherein, carboxymethyl pachyman is prepared from by the following method: poria cocos sclerotium is carried out micronizing, obtains Poria superfine powder, then with edible ethanol room temperature lixiviate, filters to obtain filter cake; Then with volume ratio be 15-10: 1 water and alcohol mixture for medium, filter cake reacts with monoxone and excessive sodium hydroxide, and purification obtains carboxymethyl pachyman.
Embodiment 2-5, comparative example 1-2
Embodiment 2-5 is different in that from embodiment 1 composition and ratio of full nutrition half digestion special medicine purposes formula food is different, is specifically shown in table 1.
The full nutrition that table 1 embodiment 2-5 provides half digests the composition and ratio of special medicine purposes formula food
(composition and ratio in every 100g nutrition half digestion special medicine purposes formula food, unit: g)
| Material name | Embodiment 2 | Embodiment 3 | Embodiment 4 | Embodiment 5 |
| Lact albumin hydrolysate | 9 | 10 | 5 | 15 |
| Albumen | 4 | 5 | 7 | 3 |
| Soybean protein isolate | 1 | 2 | 3.25 | 1 |
| Concentrated lactoalbumin | 2.2 | 1.2 | 4 | 1 |
| Sodium caseinate | 1.2 | 0.8 | 0.5 | 2 |
| Isomaltulose | 35 | 30.96 | 25 | 35 5 --> |
| Maltodextrin | 17 | 16 | 20 | 12 |
| Oligofructose | 1 | 2 | 1 | 4 |
| Carboxymethyl pachyman | 0.01 | 0.04 | 0.05 | 0.005 |
| Vegetable oil powder | 18 | 17 | 22 | 15 |
| Medium-chain fatty acid | 6 | 7 | 4 | 8 |
| Mineral substance premix | 4.99 | 7 | 8 | 3 |
| Vitamin premix | 0.6 | 1 | 0.2 | 0.995 |
Embodiment 6
The present embodiment and embodiment 1 are different in that, described mineral substance premix delicatessen food mineral substance premix, described vitamin premix is delicatessen food vitamin premix.
Comparative example 1
This comparative example and embodiment 1 are different in that, do not contain carboxymethyl pachyman.
Comparative example 2
This comparative example and embodiment 1 are different in that, do not contain maltodextrin, resistant dextrin and isomaltulose.
The full nutrition provided by the invention half digestion special medicine purposes formula food impact on mouse intestinal function:
Example 1-6 and comparative example 1-2 tests, and sets negative control group, negative control group gavage normal saline simultaneously. SPF level BALB/C mice, male, body weight 18-22g, often group 10. According to 0.05g/10g dosage gavage every day mice, continuous 10 days. To cage nursing single during mice lavage, measure it every day and take in appetite, within every 3 days, claim 1 body weight, finally calculate the increase of each group of food ration, body weight increase, calculate food exchange share. Food utilization=body weight increases (g) ÷ food weight (g) × 100%. Mouse Weight is affected result in Table 2 by full nutrition half digestion special medicine purposes formula food, and mouse chow usage factor is affected result in Table 3.
Example 1-6 and comparative example 1-2 tests, according to 0.05g/10g dosage gavage every day mice, and continuous 7 days. Can't help water 24h to fasting in the 6th of nutritional solution the day, last giving to 1h after nutritional solution takes blood with 50g/L D-xylose liquid 20mL/kg, 1h posterior orbit, separates serum. Take out 40L serum and add 4ml developer (take phloroglucinol 0.5g and add 100ml glacial acetic acid and 6ml concentrated hydrochloric acid), mixing, 100 DEG C of heating in water bath 10min, flowing water is cooled to room temperature, use 554nm wavelength, add developer pipe with distilled water and reset, measure the trap of each pipe. What mouse small intestine was absorbed by full nutrition half digestion special medicine purposes formula food affects result in Table 4.
The full nutrition of the table 2 half digestion special medicine purposes formula food impact on Mouse Weight
| First body weight (g) | Whole body weight (g) | Weightening finish (g) | |
| Embodiment 1 | 23.16 | 28.78 | 5.62 |
| Embodiment 2 | 23.40 | 28.92 | 5.52 |
| Embodiment 3 | 22.94 | 28.66 | 5.72 |
| Embodiment 4 | 22.82 | 28.80 | 5.98 |
| Embodiment 5 | 23.56 | 29.08 | 5.52 |
| Embodiment 6 | 22.56 | 28.12 | 5.64 |
| Comparative example 1 | 23.05 | 28.51 | 5.46 |
| Comparative example 2 | 22.65 | 27.69 | 5.14 |
| Negative control group | 23.12 | 21.66 | 5.54 |
As shown in Table 2, comparing with negative control group, the body weight increase of embodiment 1-6 group mice there was no significant difference (P > 0.05);Compared with comparative example 1-2, the body weight increase of embodiment 1-6 group mice also there was no significant difference (P > 0.05). Visible, Mouse Weight growth is had no and significantly affects by said preparation, it is possible to maintain the normal physiological function of mice.
The full nutrition of the table 3 half digestion special medicine purposes formula food impact on mouse chow usage factor
| Food exchange share (%) | |
| Embodiment 1 | 4.23. |
| Embodiment 2 | 4.01 |
| Embodiment 3 | 4.11 |
| Embodiment 4 | 3.94 |
| Embodiment 5 | 3.89 |
| Embodiment 6 | 4.18 |
| Comparative example 1 | 2.45 |
| Comparative example 2 | 2.68 |
| Negative control group | 2.07 |
As shown in Table 3, full nutrition provided by the invention half digestion special medicine purposes formula food can significantly improve mouse chow usage factor, is conducive to digesting and assimilating.
The impact that mouse small intestine is absorbed by the full nutrition of table 4 half digestion special medicine purposes formula food
| Number of animals | OD value | |
| Embodiment 1 | 10 | 0.91 |
| Embodiment 2 | 10 | 0.86 |
| Embodiment 3 | 10 | 0.85 |
| Embodiment 4 | 10 | 0.82 |
| Embodiment 5 | 10 | 0.79 |
| Embodiment 6 | 10 | 0.88 |
| Comparative example 1 | 10 | 0.54 |
| Comparative example 2 | 10 | 0.48 |
| Negative control group | 10 | 0.41 |
As shown in Table 4, digesting and assimilating of mice is had obvious promotion functions by full nutrition provided by the invention half digestion special medicine purposes formula food.
The full nutrition provided by the invention half digestion special medicine purposes formula food impact on immune function of mice:
Adopt mouse spleen lymphocyte transformation experiment, with reference to the method for Ministry of Public Health " health food inspection and value disciplines " (version in 2003). Mice spleen lymphocytes proliferation ability is affected result in Table 5 by full nutrition half digestion special medicine purposes formula food.
Adopt mice carbon particle clearance test, with reference to the method for Ministry of Public Health " health food inspection and value disciplines " (version in 2003). Mice Mus monocytes/macrophages function is affected result in Table 6 by full nutrition half digestion special medicine purposes formula food.
The full nutrition of the table 5 half digestion special medicine purposes formula food impact on mice spleen lymphocytes proliferation ability
| Number of animals | Optical density value | |
| Embodiment 1 | 10 | 0.183 |
| Embodiment 2 | 10 | 0.172 |
| Embodiment 3 | 10 | 0.174 |
| Embodiment 4 | 10 | 0.162 |
| Embodiment 5 | 10 | 0.159 |
| Embodiment 6 | 10 | 0.179 |
| Comparative example 1 | 10 | 0.084 |
| Comparative example 2 | 10 | 0.114 |
As shown in Table 5, compared with comparative example 1 and 2, full nutrition provided by the invention half digestion special medicine purposes formula food can significantly improve spleen lymphocyte proliferation rate, illustrate that full nutrition provided by the invention half digestion special medicine purposes formula food can be remarkably reinforced the Cell-mediated Immunity of body, improve the suppressed state of human body immune function, the specific immune function of enhancing body.
The full nutrition of the table 6 half digestion special medicine purposes formula food impact on mouse monokaryon-macrophage function
| Number of animals | Phagocytic index | |
| Embodiment 1 | 10 | 6.23 |
| Embodiment 2 | 10 | 6.10 |
| Embodiment 3 | 10 | 6.12 |
| Embodiment 4 | 10 | 5.86 |
| Embodiment 5 | 10 | 5.98 |
| Embodiment 6 | 10 | 6.15 |
| Comparative example 1 | 10 | 4.32 |
| Comparative example 2 | 10 | 5.28 |
As shown in Table 6, compared with comparative example 1 and 2, full nutrition provided by the invention half digestion special medicine purposes formula food can significantly improve the phagocytic index of monocytes/macrophages, illustrate that full nutrition provided by the invention half digestion special medicine purposes formula food is likely to be of the effect promoting monocytes/macrophages phagocytic function, the non-specific immunity of enhancing body.
Above specific embodiments of the invention being described in detail, but it is intended only as example, the present invention is not restricted to particular embodiments described above. To those skilled in the art, any equivalent modifications that the present invention is carried out and replacement are also all among scope of the invention. Therefore, the equalization made without departing from the spirit and scope of the invention converts and amendment, all should contain within the scope of the invention.
Claims (9)
1. a full nutrition half digestion special medicine purposes formula food, it is characterised in that contain in full nutrition half digestion special medicine purposes formula food described in every 100g:
Lact albumin hydrolysate 5-15g,
Albumen 3-8g,
Soybean protein isolate 1-4g,
Concentrated lactoalbumin 1-4g,
Sodium caseinate 0.5-2g,
Low GI value carbohydrate 37-60g,
Oligofructose 1-4g,
Carboxymethyl pachyman 0.005-0.05g,
Vegetable oil powder 15-22g,
Medium-chain fatty acid 4-10g,
Mineral substance premix 3-8g,
Vitamin premix 0.2-1.4g.
2. full nutrition according to claim 1 half digestion special medicine purposes formula food, it is characterised in that described low GI value carbohydrate is isomaltulose and maltodextrin mixture.
3. full nutrition according to claim 2 half digestion special medicine purposes formula food, it is characterised in that containing isomaltulose 25-40g, maltodextrin 12-20g in full nutrition half digestion special medicine purposes formula food described in every 100g.
4. full nutrition according to claim 1 half digestion special medicine purposes formula food, it is characterized in that, described vegetable oil powder is made up of vegetable oil and edible carrier, the weight ratio of the two is (40-60): (40-60), vegetable oil and edible carrier being mixed, spray drying is made powder and is namely obtained described vegetable oil powder.
5. full nutrition according to claim 1 half digestion special medicine purposes formula food, it is characterised in that contain in full nutrition half digestion special medicine purposes formula food described in every 100g:
Lact albumin hydrolysate 7-14g,
Albumen 4-6g,
Soybean protein isolate 1-3g,
Concentrated lactoalbumin 1-3g,
Sodium caseinate 0.6-1.5g,
Isomaltulose 28-38g,
Maltodextrin 14-18g,
Oligofructose 0.8-3g,
Carboxymethyl pachyman 0.008-0.04g,
Vegetable oil powder 16-20g,
Medium-chain fatty acid 5-8g,
Mineral substance premix 3.5-6g,
Vitamin premix 0.5-1.2g.
6. full nutrition according to claim 5 half digestion special medicine purposes formula food, it is characterised in that contain in full nutrition half digestion special medicine purposes formula food described in every 100g:
Lact albumin hydrolysate 9-10g,
Albumen 4-5g,
Soybean protein isolate 1-2g,
Concentrated lactoalbumin 1.2-2.2g,
Sodium caseinate 0.8-1.2g,
Isomaltulose 30-35g,
Maltodextrin 16-17g,
Oligofructose 1-2g,
Carboxymethyl pachyman 0.01-0.04g,
Vegetable oil powder 17-18g,
Medium-chain fatty acid 6-7g,
Mineral substance premix 4-5g,
Vitamin premix 0.6-1g.
7. full nutrition according to claim 6 half digestion special medicine purposes formula food, it is characterised in that contain in full nutrition half digestion special medicine purposes formula food described in every 100g:
Lact albumin hydrolysate 9.54g,
Albumen 4.73g,
Soybean protein isolate 1.66g,
Concentrated lactoalbumin 1.86g,
Sodium caseinate 0.97g,
Isomaltulose 32.86g,
Maltodextrin 16.90g,
Oligofructose 1.70g,
Carboxymethyl pachyman 0.03g,
Vegetable oil powder 17.22g,
Medium-chain fatty acid 6.83g,
Mineral substance premix 4.88g,
Vitamin premix 0.82g.
8. the full nutrition according to any claim in claim 1-7 half digestion special medicine purposes formula food, it is characterized in that, mineral substance premix described in every 1g comprises tricalcium phosphate 18-30mg, calcium carbonate 5-15mg, six hydrated chromium trichloride 0.004-0.01mg, anhydrous cupric sulfate 0.05-0.3mg, Feromax 1-2mg, magnesium chloride 12-25mg, manganese sulfate 0.1-0.5mg, two molybdic acid hydrate sodium 0.005-0.02mg, potassium chloride 18-30mg, dipotassium hydrogen phosphate 70-100mg, sodium selenite 0.001-0.01mg, Zinc sulfate monohydrate 0.8-1.5mg, sodium fluoride 0.05-0.2mg, edible salt 50-70mg, sodium citrate 18-26mg, surplus is mineral substance premix carrier.
9. the full nutrition according to any claim in claim 1-7 half digestion special medicine purposes formula food, it is characterised in that vitamin premix described in every 1g comprises phylloxanthin 0.8-1.5mg, vitamin A acid esters 1500-2500IU, vitamin D3200-300U, Vitamin E acetate 10-18mg, vitamin K10.01-0.1mg, thiamine nitrate 1-2mg, riboflavin 0.8-1.5mg, pyridoxine hydrochloride 1-2mg, ascorbic acid 60-100mg, D-VB5 calcium 2-8mg, biotin 28-40mg, folic acid 0.1-0.5mg, nicotiamide 8-15mg, vitamin B121-4mg, potassium iodide 0.05-0.1mg, choline 150-300mg, taurine 40-60mg, surplus is vitamin premix carrier.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201410287197.1A CN104082739B (en) | 2014-06-24 | 2014-06-24 | A kind of full nutrition half digestion special medicine purposes formula food and preparation method thereof |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201410287197.1A CN104082739B (en) | 2014-06-24 | 2014-06-24 | A kind of full nutrition half digestion special medicine purposes formula food and preparation method thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN104082739A CN104082739A (en) | 2014-10-08 |
| CN104082739B true CN104082739B (en) | 2016-06-15 |
Family
ID=51630587
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201410287197.1A Active CN104082739B (en) | 2014-06-24 | 2014-06-24 | A kind of full nutrition half digestion special medicine purposes formula food and preparation method thereof |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN104082739B (en) |
Families Citing this family (25)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104432062B (en) * | 2014-12-18 | 2016-04-06 | 广州纽健生物科技有限公司 | Containing the Anticancer Food of carboxymethylpachymaran |
| CN104432107B (en) * | 2014-12-18 | 2016-09-28 | 广州纽健生物科技有限公司 | Promote nutraceutical and the application of post-operative recovery |
| CN105558046A (en) * | 2016-01-12 | 2016-05-11 | 刘保惠 | Formula food with special medicinal purpose and suitable for liver disease and preparation method thereof |
| CN106666716A (en) * | 2016-11-21 | 2017-05-17 | 北京康百世科技发展有限公司 | Total-nutrient formula food for diabetic patients and preparation method thereof |
| CN106617032B (en) * | 2016-12-27 | 2020-03-17 | 麦孚营养科技（北京）有限公司 | A fluid nutritious food |
| CN107373673A (en) * | 2017-08-22 | 2017-11-24 | 河北健素临床营养有限公司 | Full nutrition formula food for the disability patient of disability caused by cardiovascular and cerebrovascular diseases half |
| CN107467193B (en) * | 2017-09-07 | 2020-12-15 | 黑龙江飞鹤乳业有限公司 | A powder food based on goat milk for special medical use and its preparation method |
| CN107712907A (en) * | 2017-09-18 | 2018-02-23 | 诺和生物技术（天津）有限公司 | Composition that a kind of suitable fat and fat reducing operation crowd eats and preparation method thereof |
| CN107692238A (en) * | 2017-09-21 | 2018-02-16 | 青岛海洋生物医药研究院股份有限公司 | Application of the oyster peptide in special medicine purposes formula food is prepared |
| CN107772472A (en) * | 2017-10-17 | 2018-03-09 | 朱晓军 | Supplement protein food and dissipate preparation method |
| CN109674065A (en) * | 2017-10-19 | 2019-04-26 | 江苏正大丰海制药有限公司 | A kind of oral complete nutritional composition |
| CN108077912A (en) * | 2017-12-25 | 2018-05-29 | 陕西三正医用营养有限公司 | A kind of full nutrition special medicine purposes formula food and preparation method thereof |
| CN110547472A (en) * | 2018-05-31 | 2019-12-10 | 南京玉鹤鸣医学营养科技股份有限公司 | peptide-containing formula food with special medical application and preparation method thereof |
| CN109043311A (en) * | 2018-06-29 | 2018-12-21 | 山东探克生物科技股份有限公司 | A kind of edible fiber products and preparation method thereof for alleviating chronic colitis |
| CN108813625A (en) * | 2018-06-29 | 2018-11-16 | 广州泽力医药科技有限公司 | Formula food and preparation method thereof |
| CN108783437A (en) * | 2018-06-29 | 2018-11-13 | 山东探克生物科技股份有限公司 | A kind of the inflammatory bowel disease full nutrition formula food and its preparation process of predigestion |
| CN108991506A (en) * | 2018-07-18 | 2018-12-14 | 辰欣药业股份有限公司 | A kind of not fibrous medical formula food of predigestion high energy and preparation method thereof |
| CN108968046A (en) * | 2018-07-25 | 2018-12-11 | 哈尔滨拜仑斯特临床营养有限公司 | A kind of special medicine purposes full nutrition formula food and preparation method thereof |
| CN111513312A (en) * | 2019-02-01 | 2020-08-11 | 吉林博雅特医营养科技有限公司 | Quinoa-containing full-nutrition special medical application formula food and preparation method thereof |
| CN110604297A (en) * | 2019-10-12 | 2019-12-24 | 襄阳市世诠生物科技有限公司 | Special medical food for old people and preparation method thereof |
| CN111418831A (en) * | 2020-03-31 | 2020-07-17 | 中国食品发酵工业研究院有限公司 | Full-nutrition formula emulsion and preparation method and application thereof |
| CN112471504A (en) * | 2020-12-15 | 2021-03-12 | 济南大学 | Special medical purpose formula food for epileptic and preparation method thereof |
| CN114794460A (en) * | 2022-05-10 | 2022-07-29 | 华中农业大学 | Immunity-enhanced full-nutrition formula food with special medical application |
| CN115251372B (en) * | 2022-08-11 | 2024-02-02 | 广州纽健生物科技有限公司 | Food suitable for non-dialysis nephrosis patient and preparation method thereof |
| CN116369513B (en) * | 2023-03-15 | 2024-03-01 | 江南大学 | Special medical use total nutrient emulsion without adding extra stabilizer and preparation method thereof |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1148791B1 (en) * | 1998-10-16 | 2002-12-11 | Societe Des Produits Nestle S.A. | Protein material for slow digestion and its use |
| CN1324580A (en) * | 2001-05-18 | 2001-12-05 | 蔡润生 | Health food containing active nutritious protein and its production process |
| US20060280840A1 (en) * | 2005-05-24 | 2006-12-14 | Robertson Marion G | Universal protein formulation meeting multiple dietary needs for optimal health and enhancing the human immune system |
| CN101502323B (en) * | 2009-03-02 | 2013-04-03 | 广州纽健生物科技有限公司 | Elemental diet suitable for severe patient and patient with metabolic intestinal dysfunction as well as preparation method thereof |
-
2014
- 2014-06-24 CN CN201410287197.1A patent/CN104082739B/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| CN104082739A (en) | 2014-10-08 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN104082739B (en) | A kind of full nutrition half digestion special medicine purposes formula food and preparation method thereof | |
| Who | Protein and amino acid requirements in human nutrition | |
| CN106072573A (en) | A kind of it is applicable to the special dietary seafood that old aged muscle decay disease is edible | |
| CN106666728A (en) | Special clinical nutrient composition for gestational diabetes and preparation method of nutrient composition | |
| CN106605908A (en) | Fully nutritional formula product with special medical purposes for liver diseases | |
| CN102423487B (en) | Osteoarticular health-care composition and its application | |
| CN104856014A (en) | Emergency food and preparation method thereof | |
| CN104853621A (en) | Nutritional formulations using human milk oligosaccharides for modulating inflammation | |
| CN108651988A (en) | Nephrosis dialysis tailored version clinical nutrition formula and preparation method thereof | |
| CN107348483A (en) | A kind of pregnant and lying-in women's full function nutritious supplementary pharmaceutical | |
| CN108991532A (en) | A kind of oral skin-beautifying agent of the collagen peptide comprising separate sources | |
| CN107440107A (en) | It is a kind of to eat the food formula of special diet containing small peptide for pregnancy reaction crowd | |
| CN108013452A (en) | A kind of puerperal abdominal flatulence gas tailored version clinical nutrition formula and preparation method thereof | |
| CN107375221A (en) | One kind contains farnoquinone calcium tablet and preparation method thereof | |
| Frank et al. | Sodium—potassium chloride mixtures as table salt | |
| CN104432107A (en) | Nutritious food for promoting postoperative recovery and application thereof | |
| CN104432062B (en) | Containing the Anticancer Food of carboxymethylpachymaran | |
| Moore et al. | The production of experimental vitamin A deficiency in rats and mice | |
| CN110214942A (en) | A kind of hyperthyroidism tailored version Nutrition formula and preparation method thereof | |
| CN105192072A (en) | Nutrient and formula milk powder for pregnant woman | |
| CN104814375A (en) | Total-nutrient formula food for tumor patient and preparation method thereof | |
| JP4526047B2 (en) | Strength enhancer | |
| CN110547472A (en) | peptide-containing formula food with special medical application and preparation method thereof | |
| CN105942510A (en) | Medical energy nutrition component applied to pregnant and lying-in women and preparation method thereof | |
| JP2016535734A (en) | Composition comprising choline and derivatives thereof, use and preparation method thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| PE01 | Entry into force of the registration of the contract for pledge of patent right |
Denomination of invention: Comprehensive nutritional and semi-digested formulated food for special medical use, and preparation method thereof Effective date of registration: 20190320 Granted publication date: 20160615 Pledgee: China Co truction Bank Corp Guangzhou economic and Technological Development Zone sub branch Pledgor: Guangzhou EnterNutr Biotechnology Co., Ltd. Registration number: 2019440000107 |
|
| PE01 | Entry into force of the registration of the contract for pledge of patent right | ||
| PC01 | Cancellation of the registration of the contract for pledge of patent right |
Date of cancellation: 20220620 Granted publication date: 20160615 Pledgee: China Co. truction Bank Corp Guangzhou economic and Technological Development Zone sub branch Pledgor: GUANGZHOU ENTERNUTR BIOTECHNOLOGY Co.,Ltd. Registration number: 2019440000107 |
|
| PC01 | Cancellation of the registration of the contract for pledge of patent right |